 low dose bacillu calmette-guerin regimen superfici bladder cancer therapi effect calmette-guerin bcg intraves therapi major advanc treatment superfici transit cell carcinoma bladder date optim treatment schedul toxic treatment signific preliminari result random ongo studi effect rel toxic low dose bcg regimen treatment superfici bladder cancer therapi total patient prophylaxi recurr stage Ta papillari tumor treatment carcinoma situ microinfiltr subepitheli connect tissu cours bcg pasteur vaccin addit cours patient induct cours mainten therapi complet respond year year prophylaxi group transurethr resect bcg transurethr resect patient group complet respons prophylaxi control therapi group patient tumor progress addit cours therapi respons rate contrari previou unsuccess intraves chemotherapi respons rate regard toxic irrit disturb fever rate literatur major complic conclus low dose pasteur strain bcg regimen effect prophylaxi recurr superfici papillari tumor treatment carcinoma situ microinfiltr subepitheli connect tissu toxic treatment low